Article | October 21, 2020

Covid-19 Impact On Bioprocessing: PART 1 Accelerating Trends

By Eric Langer, Kamna Jhamb, and Ronald Rader

Bioprocess

The Covid-19 pandemic is adversely affecting nearly all global industries and social functions. The biopharmaceutical industry and bioprocessing stand out as something of an exception. Because of the urgent demand for treatments, vaccines and assays, the pharmaceutical and biotech industries are experiencing disruptive, often chaotic, increased demands on its resources. This has begun to catalyze and accelerate a number of significant changes, including many preexisting trends. Essentially, the industry has been in a position to handle, or has already been preparing for this global, catastrophic event. A benefit of the rapid growth the industry has faced over the past 15 years has been that the industry has learned to be flexible, and to adapt quickly to change. ‘Flexibility’ has become a major consideration in facility design, and the selection of technologies, equipment and CMOs. This industry adaptability is already helping the industry re-tool for rapid development and production of pandemic vaccines, therapeutics, equipment and diagnostics; while also responding to changes that this worldwide mobilization of resources will bring to the industry.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: